Germline Genetic Associations for Hepatobiliary Cancers

Area of Science:

• Oncology
• Genetics
• Cancer Research

Background:

• Hepatobiliary cancers (HBCs), including liver, bile duct, and gallbladder cancers, cause significant global cancer deaths.
• Despite advances, HBC prognosis remains poor, with evidence suggesting a familial risk component.
• Germline genetic research has identified variants associated with HBC susceptibility.

Purpose of the Study:

• To review the hereditary genetics of HBC.
• To explore studies on single nucleotide polymorphisms (SNPs) and pathogenic/likely pathogenic (P/LP) variants in HBC patients.
• To discuss the clinical implications of genetic testing for HBC management and personalized treatments.

Main Methods:

• Review of existing literature on HBC genetics.
• Analysis of studies investigating germline variants (SNPs, P/LP variants) in HBC.
• Examination of genome-wide association studies and next-generation sequencing data.

Main Results:

• Germline variants in cancer-associated genes are linked to HBC risk.
• Multi-gene panel testing is recommended for other cancers but lags in HBC guidelines.
• Genetic testing has potential implications for personalized treatments and family member risk assessment.

Conclusions:

• Germline genetic testing holds promise for HBC management.
• Further research is needed to establish clinical guidelines for genetic testing in HBC.
• Integrating genetic testing may facilitate personalized medicine approaches for HBC patients.